Download Files:
Vildagliptin
SKU
HY-14291-10 mg
Category Reference compound
Tags Apoptosis;Dipeptidyl Peptidase;Ferroptosis, Apoptosis;Metabolic Enzyme/Protease, Metabolic Disease
$35 – $154
Products Details
Product Description
– Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1].
Web ID
– HY-14291
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C17H25N3O2
References
– [1]Wu YJ, et al. Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in associationwith its effects suppressing endoplasmic reticulum stress in db/db mice. Metabolism. 2015 Feb;64(2):226-35.|[2]Villhauer EB, et al. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem. 2003 Jun 19;46(13):2774-89.
CAS Number
– 274901-16-5
Molecular Weight
– 303.40
Compound Purity
– 99.61
SMILES
– O[C@@]1(C2)C[C@H]3C[C@H](C[C@]2(NCC(N4[C@H](C#N)CCC4)=O)C3)C1
Clinical Information
– Launched
Research Area
– Metabolic Disease
Solubility
– H2O : 50 mg/mL (ultrasonic)
Target
– Apoptosis;Dipeptidyl Peptidase;Ferroptosis
Isoform
– DPP-4
Pathway
– Apoptosis;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.